Crossject SACS
SEC Form D filing

Crossject SA

Health tech · Series A · Regulation D 506(b) · Filed June 5, 2026

Offering amount
$10.3M
Exemption
Reg D 506(b)
Issuer state
Not disclosed
Filing date
June 5, 2026
Signature date
June 5, 2026
CIK
0002136893

Summary

Auto-generated

Specialty pharmaceutical company developing needle-free injection systems, raising a $10.3M series-a.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.